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Background
Oxidant injury to the pulmonary endothelium contri-
butes to acute lung injury. We have shown that activation
of PKGI by cGMP increases protein levels of the antioxi-
dant enzymes catalase and glutathione peroxidase-1
(GPx-1) and ameliorates oxidant injury in mouse lung
endothelium [1]. Catalase and GPx-1 mRNA was not
increased. The pathway downstream of PKGI that leads
to increases in catalase and GPx-1 is unknown. The
c-Abl tyrosine kinase has been reported to regulate cata-
lase and GPx-1; fibroblasts deficient in c-Abl have
increased levels of catalase and resist oxidant injury [2-4].
We hypothesized that 1) activation of PKGI would
decrease c-Abl protein levels; and 2) inhibition of c-Abl
with imatinib would increase antioxidant proteins
and hydrogen peroxide (H2O2) degradation, attenuate
H2O2-induced endothelial permeability, and decrease
H2O2-induced cell death in mouse lung microvascular
endothelial cells (MLVMEC).
Methods
MLMVEC were isolated from wild-type (wt) and PKGI
knock-out (PKGI -/-) C57Bl/6 mice. MLMVEC were
treated for 4 hours with 8pCPT-cGMP (50 μM) or ima-
tinib. H2O2 scavenging was measured with a H2O2 elec-
trode after addition of known concentrations of H2O2 to
cells in suspension. Nuclear condensation was assessed
using fluorescence microscopy. Transendothelial resis-
tance (TER) was measured using electric cell-substrate
impedance sensing (ECIS). Proteins were quantified by
Western blotting.
Results
Treatment of wt MLMVEC with 8pCPT-cGMP signifi-
cantly decreased protein levels of c-Abl by 29% (p=0.02).
8pCPT-cGMP had no effect on cAbl in PKGI -/-
MLMVEC. 7 days of sildenafil treatment (100mg/kg/day)
[5] significantly decreased whole lung c-Abl protein by
37 % and increased whole lung catalase protein by 40%
(p<0.05 for both). Treatment of wt MLMVEC with 10
and 20 µM imatinib increased catalase protein by 16%
and 37% respectively, and GPx-1 protein levels by 24%
and 36%, respectively (p<0.05 for all values). Imatinib
(10 µM) decreased the measured peak H2O2 after addi-
tion of extracellular H2O2 (20, 50, and 100 µM) by 18%,
23%, and 9%, respectively (p ≤0.05 at all concentrations).
Imatinib (10 µM) significantly attenuated 100 and
250 µM H2O2-induced nuclear condensation by 15%
(p<0.05). Finally, imatinib (20 µM) attenuated the H2O2-
induced TER decrease in monolayers of MLMVEC
(p<0.05 by ANOVA).
Conclusion
These data suggest that cGMP, through PKGI, increases
MLMVEC antioxidant activity by down regulating the
cAbl tyrosine kinase. Inhibition of c-Abl with imatinib
attenuates oxidant-induced MLMVEC death and dys-
function, mimicking the antioxidant effects of cGMP-
PKGI signalling. The mechanism linking activated PKGI
and cAbl expression is unknown.
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